Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2020 Financial Results
CAMBRIDGE, Mass., May 13, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the […]